Skip to main content Help with accessibility Skip to main navigation

Paliperidone palmitate prolonged release suspension for injection (six monthly)

Indication

Treatment of schizophrenia in adult patients who are clinically stable on 1-monthly or 3-monthly paliperidone palmitate injectable products

Red

Brand:

Byannli

Nice TA:

Commissioning responsibility:

NHS England

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Paliperidone palmitate 6-monthly injection is recommended as a treatment option for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1-monthly or 3-monthly paliperidone palmitate injectable products:
• where treatment is in line with the recommendations within NICE CG178 for the use of depot or long-acting injectable antipsychotic medication, and
• where treatment is in line with the Lancashire Care Guidance for Prescribing Second Generation Long Acting Antipsychotic Injections.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 18 - Oct - 2022